TechCare: Mobile-AssessmenT and ThErapy for PsyCHosis: An Intervention for Clients Within the EArly InteRvention SErvice (TechCare)

May 6, 2015 updated by: Lancashire Care NHS Foundation Trust
The aim of the project is to conduct a feasibility study of the mobile phone application "TechCare" for individuals with psychosis in the North West of England.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

This feasibility study will follow the NIHR guidance on feasibility study design (NIHR, 2014) and will consist of both qualitative and quantitative components. The study will run across three strands as follows 1) Qualitative work & Systematic review 2) Test run and Intervention refinement 3) Feasibility trial.

Study Type

Interventional

Enrollment (Anticipated)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Lancashire
      • Preston, Lancashire, United Kingdom, PR2 8DW
        • Recruiting
        • Lancashire Care NHS Foundation Trust
        • Contact:
        • Contact:
        • Principal Investigator:
          • Imran B Chaudhry, MBBS MD
        • Principal Investigator:
          • Nusrat Husain, MBBS MD
        • Principal Investigator:
          • James Kelly, DClinPsych

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Each client must be accepted into the Psychosis Group of the Lancashire Early Intervention Service.
  • Ages 18 - 35 years
  • Medication stable for previous two months
  • Clients must be currently stable-The Lancashire Early Intervention Team uses a traffic light system to indicate current symptomatology and risks of each client. For this study we will use only clients with a Green Light, signifying that they are currently stable.
  • A score of 3 or more on positive symptoms on the PANSS
  • Minimum score of 1 on the Calgary depression scale.

Exclusion Criteria:

  • Drug induced psychosis
  • An acquired brain injury or learning disability
  • Clients who are undergoing assessment, not formally diagnosed and accepted into the service.
  • Lacking capacity for informed consent.
  • Ultra High Risk of Developing Psychosis Group (i.e. Prodromal, not first episode)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Feasibility Trial
The TechCare software is being developed specifically for use on a touch screen mobile phone. The mobile application will alert participants through notifications and ask a number of questions. Based on participant responses the app will provide a CBT based response to individuals or the service users preferred multimedia such as music, images and videos.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility and Acceptability
Time Frame: 36 months
We will measure feasibility and acceptability by exploring whether appropriate individuals can be identified and recruited to an open trial of TechCare; whether TechCare is an acceptable intervention for individuals with psychosis and what measures will be important for assessing the impact of TechCare on delusions and low mood in psychosis.
36 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychopathology on The Positive and Negative Syndrome Scale (PANSS)
Time Frame: 24 months
The 30- item PANSS, is a clinician administered 30 item semi structured interview which provides balanced representation of positive symptoms and negative symptoms and gauges their relationship to one another and to global/general psychopathology
24 months
Psychopathology on The Psychotic Symptom Rating Scales (PSYRATS)
Time Frame: 24 months
The PSYRATS is a semi-structured interview measuring dimensions of delusions and hallucinations.
24 months
Satisfaction with CBT therapy on the CHoice of Outcome In Cbt for psychosEs
Time Frame: 24 months
This is an outcome measure which reflects the aims of cognitive behavioural therapy for psychosis and the priorities of service users.
24 months
Mental wellbeing on the Warwick-Edinburgh Mental Well Being Scale (WEMWBS)
Time Frame: 24 months
The WEMWBS is a measure of mental wellbeing which focuses entirely on positive aspects of mental health.
24 months
Measure of core beliefs regarding self and others on the Brief Core Schema Scale
Time Frame: 24 months
This is a 24 item measure of core beliefs regarding self and others. It is a nine item scale which allows for the quantitative and subjective dimension of depression in schizophrenia.
24 months
Depression on the Calgary depression scale
Time Frame: 24 months
The CDS was developed to measure the level of depression in schizophrenia. It is a nine item scale which allows for the quantitative and subjective dimension of depression in schizophrenia.
24 months
Work and social functioning on The Work and Social Adjustment Scale
Time Frame: 24 months
This is a five item measure of perceived impairment in five areas: work, home management, social life, private leisure and relationships
24 months
Quality of life on the EuroQoL-5 Dimensions EQ5-D
Time Frame: 24 months
the measure is standardised instrument looking at quality of life across five health domains (mobility, self-care, usual activities, pain/discomfort and anxiety/depression).
24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Imran B Chaudhry, MBBS MD, Lead Consultant Psychiatrist, Lancashire Care Early Intervention Service & Hon Clinical Professor Adult Psychiatry University of Manchester
  • Principal Investigator: Nusrat Husain, MBBS MD, Reader in Psychiatry University of Manchester, Director Research Global Health Manchester Academic Health Sciences Centre & Consultant Psychiatrist Lancashire Care Early Intervention Service
  • Principal Investigator: James Kelly, DClinPsych, Lancashire Care NHS Foundation Trust Early Intervention Service

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2014

Primary Completion (Anticipated)

September 1, 2016

Study Completion (Anticipated)

September 1, 2017

Study Registration Dates

First Submitted

May 5, 2015

First Submitted That Met QC Criteria

May 6, 2015

First Posted (Estimate)

May 12, 2015

Study Record Updates

Last Update Posted (Estimate)

May 12, 2015

Last Update Submitted That Met QC Criteria

May 6, 2015

Last Verified

May 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • TechCare-LCFT

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Feasibility Studies

Clinical Trials on TechCare

3
Subscribe